Compounds > epigallocatechin gallate
Page last updated: 2024-08-24

epigallocatechin gallate and sphingosine kinase

epigallocatechin gallate has been researched along with sphingosine kinase in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Luca, T; Morré, DJ; Morré, DM1
Fujimura, Y; Huang, Y; Kay, NE; Kim, YH; Kumazoe, M; Lesnick, C; Miura, D; Shanafelt, TD; Suzuki, T; Tachibana, H; Tsukamoto, S; Ueda, N; Yamada, S; Yamashita, S1
Huang, Y; Kay, NE; Kumazoe, M; Lesnick, C; Shanafelt, TD; Tachibana, H; Tsukamoto, S1

Other Studies

3 other study(ies) available for epigallocatechin gallate and sphingosine kinase

ArticleYear
Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells.
    Journal of cellular biochemistry, 2010, Aug-15, Volume: 110, Issue:6

    Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Ceramides; Chromatography, Thin Layer; Cytosol; Dose-Response Relationship, Drug; HeLa Cells; Humans; Isoflavones; Lysophospholipids; Multienzyme Complexes; NAD; NADH, NADPH Oxidoreductases; Phosphotransferases (Alcohol Group Acceptor); Sphingolipids; Sphingomyelin Phosphodiesterase; Sphingosine

2010
Sphingosine Kinase-1 Protects Multiple Myeloma from Apoptosis Driven by Cancer-Specific Inhibition of RTKs.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:10

    Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Death-Associated Protein Kinases; Drug Synergism; Enzyme Activation; Female; Humans; Membrane Microdomains; Mice, Inbred BALB C; Multiple Myeloma; Phosphotransferases (Alcohol Group Acceptor); Receptor Protein-Tyrosine Kinases; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingosine; Xenograft Model Antitumor Assays

2015
SphK1 inhibitor potentiates the anti-cancer effect of EGCG on leukaemia cells.
    British journal of haematology, 2017, Volume: 178, Issue:1

    Topics: Antineoplastic Agents; Catechin; Cell Line, Tumor; Cell Survival; Drug Synergism; Enzyme Inhibitors; Gene Expression; Humans; Leukemia; Phosphotransferases (Alcohol Group Acceptor)

2017